Item Type | Name |
Concept
|
Hypercholesterolemia
|
Academic Article
|
A psyllium-enriched cereal for the treatment of hypercholesterolemia in children: a controlled, double-blind, crossover study.
|
Academic Article
|
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial.
|
Academic Article
|
The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study.
|
Academic Article
|
Effect of marine lipids on cholesteryl ester transfer and lipoprotein composition in patients with hypercholesterolemia.
|
Academic Article
|
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.
|
Academic Article
|
Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects.
|
Academic Article
|
Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.
|
Academic Article
|
Comparison of the effects of lean red meat vs lean white meat on serum lipid levels among free-living persons with hypercholesterolemia: a long-term, randomized clinical trial.
|
Academic Article
|
A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
|
Academic Article
|
Long-term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia.
|
Academic Article
|
The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin.
|
Academic Article
|
Incorporation of lean red meat into a National Cholesterol Education Program Step I diet: a long-term, randomized clinical trial in free-living persons with hypercholesterolemia.
|
Academic Article
|
A low-viscosity soluble-fiber fruit juice supplement fails to lower cholesterol in hypercholesterolemic men and women.
|
Academic Article
|
Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461: results of a multicenter dose-ranging study.
|
Academic Article
|
Safety profiles for the HMG-CoA reductase inhibitors: treatment and trust.
|
Academic Article
|
Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet.
|
Academic Article
|
A multiple-dose pharmacodynamic, safety, and pharmacokinetic comparison of extended- and immediate-release formulations of lovastatin.
|
Academic Article
|
A symposium: National Cholesterol Education Program Adult Treatment Panel III: Impact and implementation of the new guidelines. Introduction.
|
Academic Article
|
Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
|
Academic Article
|
Cholesterol lowering with high-viscosity hydroxypropylmethylcellulose.
|
Academic Article
|
Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease.
|
Academic Article
|
Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.
|
Academic Article
|
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia.
|
Academic Article
|
Cholesterol-lowering drugs bring benefits to high-risk populations even when LDL is normal.
|
Academic Article
|
Comparison of the efficacy of atorvastatin versus cerivastatin in primary hypercholesterolemia.
|
Academic Article
|
Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial.
|
Academic Article
|
High-molecular-weight hydroxypropylmethylcellulose taken with or between meals is hypocholesterolemic in adult men.
|
Academic Article
|
Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.
|
Academic Article
|
Strategies to improve Adult Treatment Panel III guideline adherence and patient compliance.
|
Academic Article
|
Management of hypercholesterolaemia in postmenopausal women.
|
Academic Article
|
Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia.
|
Academic Article
|
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).
|
Academic Article
|
Contemporary awareness and understanding of cholesterol as a risk factor: results of an American Heart Association national survey.
|
Academic Article
|
A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d.
|
Academic Article
|
Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia.
|
Academic Article
|
Lipid management and the elderly.
|
Academic Article
|
Food products containing free tall oil-based phytosterols and oat beta-glucan lower serum total and LDL cholesterol in hypercholesterolemic adults.
|
Academic Article
|
Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES).
|
Academic Article
|
Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
|
Academic Article
|
Use of a treatment algorithm to achieve NCEP ATP III goals with atorvastatin.
|
Academic Article
|
A comparison of Canadian and American guidelines for lipid management using data from the National Cholesterol Education Program Evaluation ProjecT Utilizing Novel E-technology (NEPTUNE) II survey.
|
Academic Article
|
Ezetimibe: a novel option for lowering cholesterol.
|
Academic Article
|
Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia.
|
Academic Article
|
Comparative effectiveness of rosuvastatin versus other statin therapies in patients at increased risk of failure to achieve low-density lipoprotein goals.
|
Academic Article
|
A review of lipid management in primary and secondary prevention.
|
Academic Article
|
Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
|
Academic Article
|
Novel nonstatin strategies to lower low-density lipoprotein cholesterol.
|
Academic Article
|
Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).
|
Academic Article
|
ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial.
|
Academic Article
|
Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
|
Academic Article
|
Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
|
Academic Article
|
Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
|
Academic Article
|
Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trials.
|
Academic Article
|
High-dose statin therapy: benefits and safety in aggressive lipid lowering.
|
Academic Article
|
Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting.
|
Academic Article
|
Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction.
|
Academic Article
|
Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.
|
Academic Article
|
Is ezetimibe/simvastatin no better than simvastatin alone? Lessons learned and clinical implications.
|
Academic Article
|
Effects of raloxifene and low-dose simvastatin coadministration on plasma lipids in postmenopausal women with primary hypercholesterolemia.
|
Academic Article
|
Focus on HDL as a therapeutic target for CAD risk reduction.
|
Academic Article
|
A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia.
|
Academic Article
|
Novel developments in omega-3 fatty acid-based strategies.
|
Academic Article
|
Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor.
|
Academic Article
|
Fluvastatin administration at bedtime versus with the evening meal: a multicenter comparison of bioavailability, safety, and efficacy.
|
Academic Article
|
Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy.
|
Academic Article
|
Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice.
|
Academic Article
|
Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).
|
Academic Article
|
A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
|
Academic Article
|
Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group.
|
Academic Article
|
Effects of dietary inulin on serum lipids.
|
Academic Article
|
Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia.
|
Academic Article
|
Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia.
|
Academic Article
|
Efficacy of simvastatin and ezetimibe in treating hypercholesterolemia.
|
Academic Article
|
Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: results of the Comparative HDL Efficacy and Safety Study (CHESS).
|
Academic Article
|
Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups.
|
Academic Article
|
Diabetes mellitus in midlife and the risk of dementia three decades later.
|
Academic Article
|
The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. A dose-controlled study.
|
Academic Article
|
Is it over for ezetimibe?
|
Academic Article
|
Effects of dietary supplementation with marine lipid concentrate on the plasma lipoprotein composition of hypercholesterolemic patients.
|
Academic Article
|
A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
|
Academic Article
|
The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients.
|
Academic Article
|
Fluvastatin Long-Term Extension Trial (FLUENT): summary of efficacy and safety.
|
Academic Article
|
Long-term blood cholesterol-lowering effects of a dietary fiber supplement.
|
Academic Article
|
Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial.
|
Academic Article
|
Efficacy of the National Cholesterol Education Program Step I diet. A randomized trial incorporating quick-service foods.
|
Academic Article
|
Cost effectiveness of treatment to National Cholesterol Education Panel (NCEP) targets with HMG-CoA reductase inhibitors. Trial design.
|
Academic Article
|
Dyslipidaemia: PCSK9 antibodies: a dividend of the genomics revolution.
|
Academic Article
|
Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
|
Academic Article
|
ETC-1002: a future option for lipid disorders?
|
Academic Article
|
Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Recent developments in the treatment of familial hypercholesterolemia: a review of several new drug classes.
|
Academic Article
|
Use of microsomal triglyceride transfer protein inhibitors in patients with homozygous familial hypercholesterolemia: translating clinical trial experience into clinical practice.
|
Academic Article
|
The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
|
Academic Article
|
The Risk of Hepatotoxicity, New Onset Diabetes and Rhabdomyolysis in the Era of High-Intensity Statin Therapy: Does Statin Type Matter?
|
Academic Article
|
Lower On-Treatment Low-Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials.
|
Academic Article
|
Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
|
Academic Article
|
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group.
|